Skip to content

Remimazolam Versus Midazolam for General Anesthesia Induction in Elderly Patients Undergoing Non-Cardiac Surgery

Effectiveness and Safety of Remimazolam Compared With Midazolam for General Anesthesia Induction in Elderly Patients Undergoing Non-Cardiac Surgery: A Prospective Observational Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07746505
Enrollment
1000
Registered
2026-08-05
Start date
2026-06-15
Completion date
2027-07-15
Last updated
2026-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aged, Anxiety, General Anesthesia, Intraoperative Hypotension

Keywords

Remimazolam, Midazolam, Elderly, Non-cardiac surgery, Anesthesia induction, Hemodynamic stability, Quality of recovery

Brief summary

This prospective observational cohort study evaluates the effectiveness and safety of two benzodiazepine sedatives-remimazolam and midazolam-used for general anesthesia induction in elderly patients (≥65 years) undergoing elective non-cardiac surgery. Elderly patients have reduced organ reserve and altered pharmacokinetics/pharmacodynamics, increasing their susceptibility to anesthesia-related complications such as intraoperative hypotension, delayed emergence, and postoperative delirium. Remimazolam, an ultra-short-acting benzodiazepine metabolized by organ-independent tissue esterases, is hypothesized to offer greater hemodynamic stability, faster recovery, and a more favorable safety profile than midazolam in this vulnerable population. Investigators prospectively observe and collect data without altering routine clinical care; the choice of sedative is made by the attending anesthesiologist according to standard practice. Propensity score methods will be used to reduce confounding by indication.

Detailed description

This is a prospective, observational, cohort study. The exposure is the benzodiazepine sedative actually used at induction; patients are grouped as the remimazolam (RM) or midazolam (MZ) cohort based on the clinical record. Induction and maintenance are individualized by the attending anesthesiologist ; investigators only observe and collect data without altering routine care. All patients receive standard monitoring (ECG, SpO₂, non-invasive/invasive blood pressure, end-tidal CO₂, anesthetic depth). Collected data include demographics, medical history and risk factors, medication history, examination and laboratory results, and intraoperative variables (ASA class, surgery type and duration, hypotension, anesthetic and opioid doses, fluid balance, blood loss, transfusion).

Interventions

None listed

Sponsors

Second Affiliated Hospital, Zhejiang University, School of Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age 65 years or older. 2. Scheduled for elective non-cardiac surgery under general anesthesia. 3. American Society of Anesthesiologists physical status I to IV. 4. Planned airway management with tracheal intubation or a laryngeal mask airway. 5. Written informed consent provided by the participant or the participant's legally authorized representative. \-

Exclusion criteria

1. Long-term preoperative benzodiazepine use. 2. Known allergy or contraindication to benzodiazepines, flumazenil, opioids, naloxone, or related drugs. 3. History of drug abuse or alcoholism within the past 2 years. 4. No preoperative cognitive assessment available. 5. Preoperative cognitive impairment, defined as a Mini-Mental State 6.Examination score less than 18. 7.Refusal to provide informed consent. \-

Design outcomes

Primary

MeasureTime frameDescription
Intraoperative Hypotension Burden Measured by the Time-Weighted Average of Mean Arterial Pressure (TWA-MAP) Below an Absolute Threshold (<65 mmHg) or a Relative Threshold (>20% Decrease From Baseline)From anesthetic induction through the end of surgery (intraoperative period)Intraoperative hypotension burden was quantified from mean arterial pressure (MAP) recordings obtained from anesthetic induction through the end of surgery (induction and maintenance periods).

Secondary

MeasureTime frameDescription
Vasoactive drug requirementInduction period and entire perioperative period Cumulative dose and frequency of vasoactive agents
Time to ExtubationDuring anesthesia emergenceTime from discontinuation of anesthetics to removal of the endotracheal tube.
Quality of Recovery at 24 Hours Postoperatively as Assessed by the Quality of Recovery-15 (QoR-15) Questionnaire24 hours after surgeryQuality of postoperative recovery will be assessed using the Quality of Recovery-15 (QoR-15) questionnaire, a 15-item patient-reported instrument covering physical comfort, physical independence, emotional state, psychological support, and pain. Each item is scored on an 11-point scale from 0 to 10. The total score ranges from 0 to 150, with higher scores indicating better quality of recovery.
Perioperative Anxiety Assessed by the Hospital Anxiety and Depression Scale - Anxiety Subscale (HADS-A)Day of surgery and postoperative day 2Perioperative anxiety was assessed using the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A). The HADS-A consists of 7 items, each rated from 0 to 3, yielding a total score ranging from 0 to 21. Higher scores indicate greater anxiety (a worse outcome).
Composite of Major Organ Complications (Postoperative Delirium, Acute Kidney Injury, Stroke, Acute Myocardial Infarction, Pulmonary Infection, In-Hospital All-Cause Mortality, Postoperative Length of Stay, and Unplanned Reoperation)From the end of surgery until hospital discharge, an average of 7 dayspostoperative delirium, acute kidney injury, stroke, acute myocardial infarction, or pulmonary infection. Postoperative delirium will be assessed using the Confusion Assessment Method or clinical documentation. Acute kidney injury will be defined according to Kidney Disease: Improving Global Outcomes criteria. Stroke and acute myocardial infarction will be diagnosed based on clinical, laboratory, electrocardiographic, imaging, and medical record evidence. Pulmonary infection will be diagnosed based on clinical symptoms, radiographic findings, laboratory results, and the need for antimicrobial treatment. In-hospital all-cause mortality will also be recorded.
Incidence of Anesthesia-Related Adverse Events (Composite)perioperativeThe number/proportion of participants experiencing one or more anesthesia-related adverse events during the perioperative period was recorded. Anesthesia-related adverse events included intraoperative awareness and postoperative nausea and vomiting (PONV).
Length of Stay in the Post-Anesthesia Care Unit (PACU)From PACU admission until PACU discharge readiness, assessed up to 24 hours after surgeryLength of stay in the post-anesthesia care unit (PACU), defined as the time from PACU admission until the patient meets PACU discharge readiness criteria, measured in minutes.

Countries

China

Contacts

CONTACTmin Yan, doctor
zryanmin@zju.edu.cn+86 13757118632

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 6, 2026